Matthew Gillespie
Pediatric Cardiology Philadelphia, PA Medical Doctor
NPI 1801815469 CMS profile 262930
3401 Civic Center Blvd, Children's Hospital Of Philadelphia - Cardiology, Philadelphia, PA 19104
General payments
$1,532,911
Research payments
$140,506
Ownership & investment interest
$0
Research they led as principal investigator
$948,348
Through program year 2025, Matthew Gillespie of Philadelphia, PA is reported in the CMS Open Payments database as having received $1,532,911 across 1,002 general payments and $140,506 in research payments paid to them. Separately, studies naming them as principal investigator received $948,348 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Pediatric Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
14 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $361,522 | 200 | |
| 2025 | Research | $963 | 2 | |
| 2024 | General | $138,002 | 96 | |
| 2024 | Research | $1,500 | 5 | |
| 2023 | General | $276,511 | 196 | |
| 2023 | Research | $7,894 | 5 | |
| 2022 | General | $186,858 | 117 | |
| 2022 | Research | $1,500 | 2 | |
| 2021 | General | $311,205 | 178 | |
| 2021 | Research | $11,175 | 5 | |
| 2020 | General | $103,354 | 77 | |
| 2020 | Research | $68,200 | 20 | |
| 2019 | General | $155,460 | 138 | |
| 2019 | Research | $49,275 | 13 |
Beside peers
- Matthew Gillespie
- Pediatric Cardiology median
- Middle half of Pediatric Cardiology
- National median
In program year 2025, general payments to Matthew Gillespie were reported at $361,522. Among 1,168 Pediatric Cardiology profiles paid that year, the median was $146 and the middle half received between $47 and $670.
Show as a table
| Year | Matthew Gillespie | Pediatric Cardiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $155,460 | $124 | $35–$516 | $163 |
| 2020 | $103,354 | $70 | $23–$326 | $114 |
| 2021 | $311,205 | $112 | $27–$445 | $132 |
| 2022 | $186,858 | $129 | $36–$680 | $149 |
| 2023 | $276,511 | $149 | $38–$826 | $160 |
| 2024 | $138,002 | $131 | $37–$652 | $164 |
| 2025 | $361,522 | $146 | $47–$670 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
1,054 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Cardiology in Pennsylvania
Bryan Goldstein
Pediatric Cardiology · Pittsburgh, PA
Howard Weber
Pediatric Cardiology · Hershey, PA
Catherine Avitabile
Pediatric Cardiology · Philadelphia, PA
Jonathan Edwards
Pediatric Cardiology · Philadelphia, PA
Joseph Rossano
Pediatric Cardiology · Philadelphia, PA
Jack Rychik
Pediatric Cardiology · Philadelphia, PA
Related records
Pediatric Cardiology in Pennsylvania
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Cardiology
Everyone recorded under this specialty, nationwide.
Doctors in Pennsylvania
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.